Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 625 pembrolizumab 606 Magnetic Resonance Spectroscopy 550 Carboplatin 448 Cisplatin 396 Cyclophosphamide 394 Biopsy 371 Paclitaxel 323 Nivolumab 322 Gemcitabine 317 Radiotherapy 283 Bevacizumab 242 Dexamethasone 222 fludarabine 213 Docetaxel 198 durvalumab 194 Oxaliplatin 187 venetoclax 186 atezolizumab 179 Fluorouracil 176 Rituximab 175 Pemetrexed 172 Capecitabine 167 Radiation 164 Doxorubicin 164 Radiosurgery 159 Ipilimumab 145 Etoposide 142 Leucovorin 140 Lenalidomide 138

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × selicrelumab × 90 days × Clear all

NCT03424005 2026-03-16

Morpheus-panBC

Hoffmann-La Roche

Phase 1/2 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡